norstella-logo-white

Biopharma’s first
fully integrated
data asset

Paving the way for breakthroughs in drug development and commercialization so you can get closer to the patient than ever before—and bring life-changing therapies to market faster.

74 billion data points.

NorstellaLinQ is the first and only fully integrated data asset combining real-world data and Norstella’s proprietary intelligence from the most trusted brands in the industry – Citeline, Evaluate, MMIT, Panalgo and The Dedham Group.

We’re setting a new standard for data integration by combining real-world data including open and closed claims, lab results, and electronic medical records with Norstella’s proprietary forecasting, clinical, regulatory, payer, and commercial intelligence data. This comprehensive approach from the most trusted brands in the industry helps you find the fastest path from pipeline to patient

data-map

Empowering teams across the
product lifecycle

NorstellaLinQ gives your teams access to better data and stronger insights so they can make rapid, confident, data-driven decisions while eliminating human error and bias.

Fusing machine learning, AI, and decades of historical data, NorstellaLinQ’s predictive capabilities are supported by hundreds of MDs, epidemiologists, PhDs, pharmacists, technologists and data scientists.

Clinical operations teams

Optimize protocol design, site and investigator selection.

Clinical trial teams

Identify and recruit medically complex
patients into treatment.

Brand teams

Anticipate patient behavior using predictive analytics to identify clinical symptoms, enabling earlier diagnosis.

Pharma teams

Understand clinical decision making sentiment and impact of patient adherence on clinical outcomes, reimbursement challenges, or denials by analyzing physician notes.

HEOR and epidemiology teams

Generate evidence for improved patient outcomes and cost benefit analysis from the largest patient-level dataset.

Commercial teams

Reach physicians treating specific conditions by hyper targeting patients with varying clinical criteria.

Market access teams

Track time to treatment in areas of restrictive behavior and advocate for open access speeding time to therapy.

Unparalleled data.
Unmatched expertise.

When you choose NorstellaLinQ, you gain access to the industry’s most comprehensive proprietary and patient data, supported by an expert team of MDs, epidemiologists, PhDs, pharmacists, technologists and data scientists dedicated to driving better outcomes.

With AI-driven insights that simplify decision-making, NorstellaLinQ reduces complexity, accelerates processes, and delivers actionable recommendations. Its patient-centered analysis helps you get closer to patients and the treatments they need, faster.

See the data

data-flow

Learn how NorstellaLinQ helps you bring life-changing therapies to market faster.